| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 152, Issue 11 5468-5476, Copyright © 1994 by American Association of Immunologists
ARTICLES |
I Leal-Berumen, P Conlon and JS Marshall
Department of Pathology, McMaster University, Hamilton, Ontario, Canada.
Mast cells produce a number of cytokines including IL-6. In view of the large amounts of de novo synthesis induced by the activation of rat peritoneal mast cells and previous observations of expression of this cytokine by human lung mast cells, we have studied the regulation of IL- 6 production. We examined the hypothesis that mast cell IL-6 production is not related to previous histamine release. Highly purified rat peritoneal mast cells were activated with anti-IgE, calcium ionophore A23187, or LPS. Histamine was used as a marker of preformed mediator release and IL-6 production was assessed by using the B9 hybridoma growth factor bioassay. Anti-IgE activation of rat peritoneal mast cells induced IL-6 production and histamine release. In contrast, LPS activation induced substantial, serum-dependent, IL-6 production without a significant level of histamine release. No preformed IL-6 was detected in the cells. Calcium ionophore induced histamine release from mast cells to a greater extent than did anti-IgE, but no A23187-induced IL-6 production was observed. A23187-treated cells retained high viability and produced a significant amount of TNF-alpha. To further examine the concordance of IL-6 production and histamine release we used mast cell stabilizing drugs. Dexamethasone and nedocromil significantly inhibited IL-6 production in response to anti-IgE. Our results demonstrate that there is not a direct relationship between mast cell degranulation and IL-6 production. Our observations are important for understanding the role of mast cells in inflammation and for developing strategies to modulate mast cell function in disease.
This article has been cited by other articles:
|
|
 |
|
  J Wang and M Hauer-Jensen Neuroimmune interactions: potential target for mitigating or treating intestinal radiation injury Br. J. Radiol., September 1, 2007; 80(Special_Issue_1): S41 - S48. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. G Papadopoulou, L. Oleson, D. Kempuraj, J. Donelan, C. L Cetrulo, and T. C Theoharides Regulation of corticotropin-releasing hormone receptor-2 expression in human cord blood-derived cultured mast cells J. Mol. Endocrinol., December 1, 2005; 35(3): R1 - R8. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Jawdat, E. J. Albert, G. Rowden, I. D. Haidl, and J. S. Marshall IgE-Mediated Mast Cell Activation Induces Langerhans Cell Migration In Vivo J. Immunol., October 15, 2004; 173(8): 5275 - 5282. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Ryzhov, A. E. Goldstein, A. Matafonov, D. Zeng, I. Biaggioni, and I. Feoktistov Adenosine-Activated Mast Cells Induce IgE Synthesis by B Lymphocytes: An A2B-Mediated Process Involving Th2 Cytokines IL-4 and IL-13 with Implications for Asthma J. Immunol., June 15, 2004; 172(12): 7726 - 7733. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Kandere-Grzybowska, R. Letourneau, D. Kempuraj, J. Donelan, S. Poplawski, W. Boucher, A. Athanassiou, and T. C. Theoharides IL-1 Induces Vesicular Secretion of IL-6 without Degranulation from Human Mast Cells J. Immunol., November 1, 2003; 171(9): 4830 - 4836. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Gonzalez-Espinosa, S. Odom, A. Olivera, J. P. Hobson, M. E. C. Martinez, A. Oliveira-dos-Santos, L. Barra, S. Spiegel, J. M. Penninger, and J. Rivera Preferential Signaling and Induction of Allergy-promoting Lymphokines Upon Weak Stimulation of the High Affinity IgE Receptor on Mast Cells J. Exp. Med., June 2, 2003; 197(11): 1453 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. McCurdy, T. J. Olynych, L. H. Maher, and J. S. Marshall Cutting Edge: Distinct Toll-Like Receptor 2 Activators Selectively Induce Different Classes of Mediator Production from Human Mast Cells J. Immunol., February 15, 2003; 170(4): 1625 - 1629. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T.-J. Lin, L. H. Maher, K. Gomi, J. D. McCurdy, R. Garduno, and J. S. Marshall Selective Early Production of CCL20, or Macrophage Inflammatory Protein 3{alpha}, by Human Mast Cells in Response to Pseudomonas aeruginosa Infect. Immun., January 1, 2003; 71(1): 365 - 373. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Masuda, Y. Yoshikai, K. Aiba, and T. Matsuguchi Th2 Cytokine Production from Mast Cells Is Directly Induced by Lipopolysaccharide and Distinctly Regulated by c-Jun N-Terminal Kinase and p38 Pathways J. Immunol., October 1, 2002; 169(7): 3801 - 3810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E. Applequist, R. P. A. Wallin, and H.-G. Ljunggren Variable expression of Toll-like receptor in murine innate and adaptive immune cell lines Int. Immunol., September 1, 2002; 14(9): 1065 - 1074. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Beckmann, B. Tigani, R. Sugar, A. D. Jackson, G. Jones, L. Mazzoni, and J. R. Fozard Noninvasive detection of endotoxin-induced mucus hypersecretion in rat lung by MRI Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L22 - L30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. T. M. Boudreau, R. Garduno, and T.-J. Lin Protein Phosphatase 2A and Protein Kinase Calpha Are Physically Associated and Are Involved in Pseudomonas aeruginosa-induced Interleukin 6 Production by Mast Cells J. Biol. Chem., February 8, 2002; 277(7): 5322 - 5329. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. D. McCurdy, T.-J. Lin, and J. S. Marshall Toll-like receptor 4-mediated activation of murine mast cells J. Leukoc. Biol., December 1, 2001; 70(6): 977 - 984. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Supajatura, H. Ushio, A. Nakao, K. Okumura, C. Ra, and H. Ogawa Protective Roles of Mast Cells Against Enterobacterial Infection Are Mediated by Toll-Like Receptor 4 J. Immunol., August 15, 2001; 167(4): 2250 - 2256. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. A. Vallance, P. A. Blennerhassett, J. D. Huizinga, and S. M. Collins Mast cell-independent impairment of host defense and muscle contraction in T. spiralis-infected W/WV mice Am J Physiol Gastrointest Liver Physiol, April 1, 2001; 280(4): G640 - G648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Stassen, C. Muller, M. Arnold, L. Hultner, S. Klein-Hessling, C. Neudorfl, T. Reineke, E. Serfling, and E. Schmitt IL-9 and IL-13 Production by Activated Mast Cells Is Strongly Enhanced in the Presence of Lipopolysaccharide: NF-{{kappa}}B Is Decisively Involved in the Expression of IL-9 J. Immunol., April 1, 2001; 166(7): 4391 - 4398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F.-G. Zhu and J. S. Marshall CpG-containing oligodeoxynucleotides induce TNF-{alpha} and IL-6 production but not degranulation from murine bone marrow-derived mast cells J. Leukoc. Biol., February 1, 2001; 69(2): 253 - 262. [Abstract] [Full Text]
|
|
|
|
|
|
A.-M. Coelho, J. Fioramonti, and L. Bueno Systemic lipopolysaccharide influences rectal sensitivity in rats: role of mast cells, cytokines, and vagus nerve Am J Physiol Gastrointest Liver Physiol, October 1, 2000; 279(4): G781 - G790. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. King, J. S. Marshall, H. Alshurafa, and R. Anderson Release of Vasoactive Cytokines by Antibody-Enhanced Dengue Virus Infection of a Human Mast Cell/Basophil Line J. Virol., August 1, 2000; 74(15): 7146 - 7150. [Abstract] [Full Text]
|
|
|
|
|
|
T.-J. Lin, T. B. Issekutz, and J. S. Marshall Human Mast Cells Transmigrate Through Human Umbilical Vein Endothelial Monolayers and Selectively Produce IL-8 in Response to Stromal Cell-Derived Factor-1{alpha} J. Immunol., July 1, 2000; 165(1): 211 - 220. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Song, H. Haleem-Smith, R. Arudchandran, J. Gomez, P. M. Scott, J. F. Mill, T.-H. Tan, and J. Rivera Tyrosine Phosphorylation of Vav Stimulates IL-6 Production in Mast Cells by a Rac/c-Jun N-Terminal Kinase-Dependent Pathway J. Immunol., July 15, 1999; 163(2): 802 - 810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S C Bischoff, A Lorentz, S Schwengberg, G Weier, R Raab, and M P Manns Mast cells are an important cellular source of tumour necrosis factor alpha in human intestinal tissue Gut, May 1, 1999; 44(5): 643 - 652. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. S. Marshall, K. Gomi, M. G. Blennerhassett, and J. Bienenstock Nerve Growth Factor Modifies the Expression of Inflammatory Cytokines by Mast Cells Via a Prostanoid-Dependent Mechanism J. Immunol., April 1, 1999; 162(7): 4271 - 4276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Talkington and S. P. Nickell Borrelia burgdorferi Spirochetes Induce Mast Cell Activation and Cytokine Release Infect. Immun., March 1, 1999; 67(3): 1107 - 1115. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Arock, E. Ross, R. Lai-Kuen, G. Averlant, Z. Gao, and S. N. Abraham Phagocytic and Tumor Necrosis Factor Alpha Response of Human Mast Cells following Exposure to Gram-Negative and Gram-Positive Bacteria Infect. Immun., December 1, 1998; 66(12): 6030 - 6034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T.-J. Lin, N. Hirji, O. Nohara, G. R. Stenton, M. Gilchrist, and A. D. Befus Mast Cells Express Novel CD8 Molecules That Selectively Modulate Mediator Secretion J. Immunol., December 1, 1998; 161(11): 6265 - 6272. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Sewell, L. L. Scurr, H. Orphanides, S. Kinder, and R. I. Ludowyke Induction of Interleukin-4 and Interleukin-5 Expression in Mast Cells Is Inhibited by Glucocorticoids Clin. Vaccine Immunol., January 1, 1998; 5(1): 18 - 23. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. Gagari, M. Tsai, C. S. Lantz, L. G. Fox, and S. J. Galli Differential Release of Mast Cell Interleukin-6 Via c-kit Blood, April 15, 1997; 89(8): 2654 - 2663. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
